Allergan sets special meeting date

Allergan Inc. (NYSE:AGN) set a Dec. 18 date for a special shareholder meeting at which Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX) and hedge fund Pershing Square Capital hope to install board members who would approve Valeant's hostile takeover bid. Valeant and Pershing Square are suing Allergan and seeking a November date.

In its own lawsuit, Allergan alleges that Valeant, Pershing Square and its manager violated insider trading laws. Allergan said Wednesday that it is seeking a federal court order to strip those parties of voting rights it alleges they acquired illegally. ...